Will Natco and Dr. Reddy’s bet on weight-loss drug Ozempic’s copy pay off?
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
Tom Redmond Sr., Aussie Hair Care Founder, Dies at 92
Hair care entrepreneur Tom Redmond Sr. died Feb. 13 at the age of 92. He died of natural causes, according to a ...
FiercePharma12h
As BMS-paired triplet misses survival mark in kidney cancer, Exelixis shifts focus elsewhere
Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...
BioSpace16h
After 10 Years of Hard Work, COUR Treads Into Pharma’s Myasthenia Gravis Territory
COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...
Richmond16h
Drugmakers fighting hard in Virginia to keep control of medicine prices
Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...
EurekAlert!1d
Radiation plus combination immunotherapy may help preserve bladder in some patients with muscle-invasive bladder cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
Bristol Myers announces new five-year results from POETYK PSO trial
Squibb announced new five-year results from the POETYK PSO long-term extension, LTE, trial of Sotyktu treatment in adult ...
Medscape1d
Obinutuzumab a Success in Phase 3 Trial for Lupus Nephritis
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
Hosted on MSN1d
Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer
A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally ...